BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6544812)

  • 1. Bone and liver images in medullary carcinoma of the thyroid gland: concise communication.
    Johnson DG; Coleman RE; McCook TA; Dale JK; Wells SA
    J Nucl Med; 1984 Apr; 25(4):419-22. PubMed ID: 6544812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radionuclide liver and bone scanning in the evaluation of patients with endometrial carcinoma.
    Mettler FA; Christie JH; Garcia JF; Baldwin MH; Wicks JD; Bartow SA
    Radiology; 1981 Dec; 141(3):777-80. PubMed ID: 6272356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tc-99m-(V)-DMSA: the new sensitive and specific radiopharmaceutical for imaging metastases of medullary thyroid carcinomas?
    Becker W; Börner W; Reiners C
    Horm Metab Res Suppl; 1989; 21():38-42. PubMed ID: 2553574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
    Clarke SE; Lazarus CR; Wraight P; Sampson C; Maisey MN
    J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentavalent Tc-99m DMSA scintigraphy. Prospective evaluation of its role in the management of patients with medullary carcinoma of the thyroid.
    Mojiminiyi OA; Udelsman R; Soper ND; Shepstone BJ; Dudley NE
    Clin Nucl Med; 1991 Apr; 16(4):259-62. PubMed ID: 1646098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualization of hepatic metastases of medullary thyroid carcinoma on Tc-99m MDP bone scintigraphy.
    Ali I; Johns W; Gupta SM
    Clin Nucl Med; 2006 Oct; 31(10):611-3. PubMed ID: 16985365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medullary thyroid carcinoma with radioiodide transport. Effects of iodine-131 therapy and lithium administration.
    Michael BE; Forouhar FA; Spencer RP
    Clin Nucl Med; 1985 Apr; 10(4):274-9. PubMed ID: 3158460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Massive splenic metastases with localization of a skeletal imaging agent.
    Shih WJ; Domstad PA; Purcell M; DeLand FH
    Radiat Med; 1986; 4(1):1-4. PubMed ID: 3775066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of bone and liver scans in surveying patients with breast cancer for metastatic disease.
    Evans DM; Wright DJ
    Am Surg; 1987 Oct; 53(10):603-5. PubMed ID: 2823653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma.
    Manil L; Boudet F; Motte P; Gardet P; Saccavini JC; Lumbroso JD; Schlumberger M; Caillou B; Bazin JP; Ricard M
    Cancer Res; 1989 Oct; 49(19):5480-5. PubMed ID: 2766309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isotopic localization of hepatic metastasis of medullary carcinoma of the thyroid with Tc-99 pyrophosphate].
    Salmerón de Diego J; Bittini Copano A; Domínguez Montero P; Jara Albarrán A
    Med Clin (Barc); 1985 Sep; 85(9):385. PubMed ID: 3001450
    [No Abstract]   [Full Text] [Related]  

  • 12. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
    Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y
    J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new imaging agent for medullary carcinoma of the thyroid.
    Ohta H; Yamamoto K; Endo K; Mori T; Hamanaka D; Shimazu A; Ikekubo K; Makimoto K; Iida Y; Konishi J
    J Nucl Med; 1984 Mar; 25(3):323-5. PubMed ID: 6321700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of radionuclide images and radiographs for skeletal metastases from renal cell carcinoma.
    Kim EE; Bledin AG; Gutierrez C; Haynie TP
    Oncology; 1983; 40(4):284-6. PubMed ID: 6223255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine.
    Sone T; Fukunaga M; Otsuka N; Morita R; Muranaka A; Yanagimoto S; Tomomitsu T; Nakayama H; Harada T
    J Nucl Med; 1985 Jun; 26(6):604-8. PubMed ID: 3158726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of medullary carcinoma of thyroid, with liver metastasis, using 99mTc DMSA(V) scintigraphy.
    Shikare S; Bashir K; Menon PS; Bapat RD; Tilve GH
    J Postgrad Med; 1995; 41(1):12-3. PubMed ID: 10740693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radionuclide imaging in medullary thyroid carcinoma: evaluation of two new radiopharmaceuticals.
    Clarke SE; Lazarus CR; Maisey MN
    Henry Ford Hosp Med J; 1987; 35(2-3):124-6. PubMed ID: 2826368
    [No Abstract]   [Full Text] [Related]  

  • 18. Usefulness of the 99mTc-MDP scan in the detection of calcified liver metastases.
    Tokuue K; Furuse M
    Nuklearmedizin; 1990 Nov; 29(5):231-3. PubMed ID: 2277774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radionuclide scanning in children with rhabdomyosarcoma.
    Weinblatt ME; Miller JH
    Med Pediatr Oncol; 1981; 9(3):293-301. PubMed ID: 7242467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical uptake of 99m Tc-HMDP in a patient with metastatic liver disease.
    Moya Espinosa P; Amrani Raissouni T; Ramos Moreno E; Martínez del Valle Torres MD; Ortega Lozano SJ; Jiménez-Hoyuela García JM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):350-1. PubMed ID: 23169390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.